PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1620.28%
Some net income increase while SUM is negative at -0.85%. John Neff would see a short-term edge over the struggling competitor.
27.95%
Some D&A expansion while SUM is negative at -5.02%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
No Data
No Data available this quarter, please select a different quarter.
23.14%
SBC growth while SUM is negative at -100.00%. John Neff would see competitor possibly controlling share issuance more tightly.
200.00%
Well above SUM's 71.81% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-363.96%
AR is negative yoy while SUM is 100.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
116.72%
Inventory growth well above SUM's 100.00%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Some yoy usage while SUM is negative at -137.87%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-190.32%
Both negative yoy, with SUM at -93.53%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
318.04%
Operating cash flow growth above 1.5x SUM's 53.56%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-18.06%
Negative yoy CapEx while SUM is 15.55%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
80.16%
Less M&A spending yoy vs. SUM's 635.05%, reducing near-term risk. David Dodd would confirm the firm is not missing out on a strategic deal that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-137.77%
Both yoy lines negative, with SUM at -7.11%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-1.45%
We reduce yoy invests while SUM stands at 70.54%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-200.00%
We cut debt repayment yoy while SUM is 58.02%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Buyback growth of 200.00% while SUM is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.